ReviewRadiologie (Heidelberg, Germany)2026
[Intramedullary spinal cord tumors : MRI diagnosis and differential diagnosis].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntramedullary spinal cord tumors are rare neoplasms but frequently cause significant neurological deficits because of the limited compensatory capacity of the spinal cord. Magnetic resonance imaging (MRI) is the imaging modality of choice and often allows a reliable differential diagnosis based on characteristic imaging findings.
objectivesTo provide a practical neuroradiological approach to the diagnosis of intramedullary spinal cord tumors, including recent developments in the World Health Organization (WHO) classification. MATERIALS AND
methodsNarrative review of the current literature regarding epidemiology, imaging characteristics, WHO classification, and differential diagnosis of intramedullary spinal cord tumors.
resultsEpendymomas, astrocytomas, and hemangioblastomas account for the majority of intramedullary tumors. Tumor location, longitudinal extent, enhancement pattern, hemorrhagic components, syringomyelia, and flow voids substantially narrow the differential diagnosis. Recent WHO classifications increasingly incorporate molecular markers, including MYCN-amplified spinal ependymoma and H3 K27-altered diffuse midline glioma.
conclusionStructured MRI assessment frequently enables a reliable preoperative diagnosis. Inflammatory, vascular, and ischemic disorders must always be considered as important differential diagnoses.
Indexed as
Identifiers
42714480What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.